Navigation Links
In New Study, Duloxetine Was Equally Effective, Regardless of,Switch Method, in Reducing Painful Symptoms in Ssri Non- or,Partial-responders with Depression

ng of the study. The dosage could be increased to a maximum of 120 mg/day based on the investigator’s discretion.1

The primary data disclosure took place at a major medical conference in December 2006.5 The primary objective of the overall study was to demonstrate the non-inferiority of Direct Switch (DS) compared with Start-taper Switch (STS) based on changes in HAMD17 total scores. Overall, that initial data disclosure showed that switch to duloxetine was associated with significant improvements in the emotional symptoms of depression, and was well tolerated and safe, regardless of which SSRI the patient was taking at study entry.

This new analysis focused on the prevalence and severity of painful symptoms following the switch to duloxetine and in relation to switch method. The study participants, as a group, had average pain scores indicating clinically significant physical pain. Ten weeks after switching to duloxetine, patients made significant improvements on all pain measures evaluated, regardless of which switch method was used.1

Efficacy, safety, and tolerability outcomes following Direct Switch (DS) from SSRI to duloxetine were similar to those observed for Start-taper Switch (STS). The most commonly reported adverse events in the study were headache (13.1 percent for DS vs. 9.7 percent STS), dry mouth (10.4 percent DS vs. 11.9 percent STS), and nausea (8.2 percent DS vs. 8.1 percent STS). No adverse event was reported by significantly more patients in one group compared with the other. An excess of adverse events was not evident following switch from any particular SSRI.1

“This study provides some much-needed clinical evidence to help physicians successfully switch patients from one antidepressant to another when they remain depressed,” Montejo said. “It also highlights the continued prevalence and severity of painful symptoms among patie
'"/>




Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. In New Study, Duloxetine Reduced Non-specific Pain and Emotional Symptoms Associated with Depression
2. Newly Published Data Demonstrates Superiority of Cipralex Over Duloxetine for Acute Treatment of Depression
3. Roxro Pharma’s Novel Intranasal Pain Reliever Effective, Well Tolerated in Phase 3 Study
4. MabThera Significantly Increases Survival of Lymphoma Patients Regardless of Chemotherapy Regimen
5. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
6. Cimzia Effective in Reducing Signs and Symptoms of Rheumatoid Arthritis
7. The Lancet Publishes PREVAIL Study Results Showing Lovenox Superiority Over Unfractionated Heparin for Reducing the Risk of Venous ThromboEmbolism in Patients With Acute Ischemic Stroke
8. The International Myeloma Foundation Says New Clinical Trial Results Could Improve Survival While Reducing Side Effects For Many Patients
9. New Study Confirms Role for Pertussis Immunization of Entire Family in Reducing Infant Pertussis
10. Dharma Therapeutics Shows IDDS Is Effective in Reducing Pain Associated With Insertion of an Intravenous Catheter in Their Phase 2 Clinical Trial
11. Pooled Studies Showed Desvenlafaxine Succinate Significantly Improved Painful Symptoms and Anxious Symptoms Associated with Major Depressive Disorder in Adults, Compared With Placebo
Post Your Comments:
(Date:5/5/2015)... May 5, 2015   InspireMD, Inc. (NYSE MKT: ... systems, announced today that it will release its full financial ... Monday, May 11 th before the open, followed by ... financial results and business outlook. Participants should call ... 542-4135 (International) and request the InspireMD call. A live webcast ...
(Date:5/5/2015)... Ill. , May 5, 2015 ... diagnostic testing equipment and information systems technology, today ... information systems company. This partnership allows Sysmex and ... and interfacing solution for physician offices and clinics ... directly to Electronic Medical Record (EMR) systems. ...
(Date:5/5/2015)... 5, 2015 GW Pharmaceuticals plc (Nasdaq: ... biopharmaceutical company focused on discovering, developing and commercializing ... announced today the closing of the previously announced ... of 1,600,000 American Depositary Shares (ADSs) at a ... of approximately $179.2 million (before deducting underwriting discount, ...
Breaking Medicine Technology:InspireMD to Report Financial Results for the First Quarter Ended March 31, 2015 on Monday, May 11th 2InspireMD to Report Financial Results for the First Quarter Ended March 31, 2015 on Monday, May 11th 3Sysmex America, Inc. Partners with Medicus Middleware to Provide Physician Office Labs with Instrument Connectivity Directly to EMR 2Sysmex America, Inc. Partners with Medicus Middleware to Provide Physician Office Labs with Instrument Connectivity Directly to EMR 3GW Pharmaceuticals plc Announces the Closing of U.S. Public Offering of American Depositary Shares (ADSs) Raising Approximately $179.2 Million on the NASDAQ Global Market 2GW Pharmaceuticals plc Announces the Closing of U.S. Public Offering of American Depositary Shares (ADSs) Raising Approximately $179.2 Million on the NASDAQ Global Market 3GW Pharmaceuticals plc Announces the Closing of U.S. Public Offering of American Depositary Shares (ADSs) Raising Approximately $179.2 Million on the NASDAQ Global Market 4
... , CVS/pharmacy and the New York State Fraternal Order of ... Outreach yet , PORT JERVIS, N.Y., Dec. 17 On ... of Police and dozens of volunteers came together at Easter ... Jervis, to distribute toys, coats and food to families in ...
... , LITTLE FALLS, N.J., Dec. 17 CANTEL MEDICAL ... Board of Directors intends to pay, for the first time, a ... share annually, on the Company,s common stock. The Board declared the ... to be paid on January 29, 2010 to shareholders of record ...
Cached Medicine Technology:CVS/pharmacy and the New York State Fraternal Order of Police Help Families in Port Jervis Have a Merry and Memorable Holiday Season 2Cantel Medical Authorizes Semiannual Dividend 2
(Date:5/5/2015)... CA (PRWEB) May 05, 2015 With ProPoint: ... all within Final Cut Pro X . With ... within 3D space to further more customize each preset all ... users are given up to 90 fully customizable effect presets ... boxes, circles, curved arrows, straight arrows, underlines, and more. ...
(Date:5/5/2015)... Cosmetic Dentist, Arthur Glosman released a luxury line of advanced ... offices of Arthur Glosman DDS, 450 N Roxbury Drive Suite ... store . “I wanted to be one of the first ... with a luxurious collection of products designed to make you ... Glosman’s Advanced Dental Health + Beauty™ products use a potent ...
(Date:5/5/2015)... New Jersey (PRWEB) May 05, 2015 ... has maintained its strong and secure credit rating of ... of Horizon BCBSNJ’s financials last week, the Wall Street ... adequacy” and “leading market position” in determining the rating ... of mind is one of our top priorities, so ...
(Date:5/5/2015)... 05, 2015 Hundreds of ... on behalf of men who allegedly suffered ... of prescription testosterone replacement therapies continue to ... underway in U.S. District Court, Northern District ... May 1st, defendants AbbVie, Inc., Auxilium Pharmaceuticals, ...
(Date:5/5/2015)... Sunny skies and cool temperatures made for great ... runners and walkers participated in Global Lyme Alliance’s (GLA) inaugural ... , The 5K and 10K runs and 1-and 3-mile walks ... raise funds for tick-borne disease research. The “Lyme Walk and ... merger of Lyme Research Alliance (LRA) and Tick-Borne Disease ...
Breaking Medicine News(10 mins):Health News:FCPX Plugin Developer Pixel Film Studios release Propoint Hand Drawn 2Health News:Beverly Hills Dentist Arthur Glosman Launches New Dental Health And Beauty Product Line 2Health News:Horizon Blue Cross Blue Shield of New Jersey Maintains “A” Credit Rating from Standard & Poor’s 2Health News:Federal Testosterone Lawsuit Defendants Recently Submitted Answers to Master Long Form Complaint 2Health News:Federal Testosterone Lawsuit Defendants Recently Submitted Answers to Master Long Form Complaint 3Health News:Federal Testosterone Lawsuit Defendants Recently Submitted Answers to Master Long Form Complaint 4Health News:1st Annual “Lyme Walk & Run” Event a Huge Success 2Health News:1st Annual “Lyme Walk & Run” Event a Huge Success 3
... sensitive tooth at some point of their life. A visit to ... or 'you brush in a hard way, so your teeth are ... out with a solution that could make sensitive teeth a bad ... out the dentinal tubules which transmit painful signals to the pulp, ...
... to fund a study which helps to understand the ... to breast cancer patients to ease the pain they ... study is to be carried out by Researchers from ... the three complementary therapy methods reflexology, guided imagery and ...
... one of the most common breathing problems encountered by ... has been a considerable increase in the incidence of ... been estimated that nearly 196,000 children are hospitalized in ... considerable amount is being spent on the health issue ...
... loss of motor function in a part due to ... Lateral Sclerosis// is a form of motor neuron disease ... incapable of even the slightest movements such as blinking. ... ,The new headband that has been developed by Japanese ...
... year India’s Health care has been in constant limelight ... the healthcare system in India came to focus after ... the City leaving thousands homeless, many orphaned and a ... worked quickly and effectively with the people providing immediate ...
... Phase II study to 12 months confirm the significant effects ... patients with relapsing multiple sclerosis (MS). ,The data, ... both patient groups taking FTY720 (1.25 mg and 5 mg) ... of more than 50% during the first six months of ...
Cached Medicine News:Health News:Improved parent-physician communication to prevent hospitalizations for childhood asthma 2Health News:Novartis MS Drug Shows Promising Results 2Health News:Novartis MS Drug Shows Promising Results 3
ACMI™ Double-J Closed Tip Ureteral Stents feature patented dual durometer thermosensitive Tecoflex® construction for physician ease of placement and patient comfort....
Used for retrograde positioning of a ureteral stent. The radiopaque band improves fluoroscopic visibility of the positioner tip. Supplied sterile in peel-open packages. Intended for one-time use....
... placement to stent the ureter ... continent urinary diversions. Supplied sterile ... one-time use. CAUTION: Periodic evaluation ... remain indwelling more than six ...
... The Bard® C-Max™ Cutting Loop is ... smooth tissue cut. The cutting loops are ... standard. The tungsten wire-cutting loop is hand ... process. These electrodes are made to exacting ...
Medicine Products: